De novo
Showing 1 - 25 of 5,435
Entresto Versus ACEi/ARB in de Novo Heart Failure Patients
Completed
- de Novo Heart Failure
-
East Hanover, New JerseyNovartis
Jul 19, 2023
Drug-coated Balloon, Drug-eluting Stent, De Novo Stenosis Trial in Beijing (Drug-coated balloon (Bingo© [Paclitaxel-coated
Recruiting
- Drug-coated Balloon
- +2 more
- Drug-coated balloon (Bingo© [Paclitaxel-coated Balloon], Yinyi Ltd., China)
- Drug-eluting stent
-
Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases，Chin
Oct 14, 2023
Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)
Not yet recruiting
- Acute Myeloid Leukemia in Children
- Standard Intervention
- Investigational Intervention
- (no location specified)
Aug 8, 2023
Early Detection of de Novo Cancer in Liver Transplant Recipients
Completed
- De Novo Cancer
- Liver Transplant Disorder
- (no location specified)
Aug 5, 2022
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
- (no location specified)
May 29, 2023
De Novo Metabolic Syndrome in Liver Transplant Patients After
Completed
- Single Transplant
- 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
-
Rome, ItalyRoberta Angelico
Mar 29, 2023
Acute Myeloid Leukemia Trial in Taipei
Enrolling by invitation
- Acute Myeloid Leukemia
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 9, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 1, 2023
Coronary Artery Disease Trial
Not yet recruiting
- Coronary Artery Disease
- (no location specified)
Jun 19, 2023
Kidney Transplant Rejection Trial (Enteric-Coated Mycophenolate Sodium (EC-MPS))
Not yet recruiting
- Kidney Transplant Rejection
- Enteric-Coated Mycophenolate Sodium (EC-MPS)
- (no location specified)
May 23, 2023
Kidney Transplant; Complications, CMV Trial (Letermovir 480 mg once daily, Historical/Control)
Not yet recruiting
- Kidney Transplant; Complications
- CMV
- Letermovir 480 mg once daily
- Historical/Control
- (no location specified)
Aug 14, 2023
Coronary Artery Disease Trial (DES, DCB)
Not yet recruiting
- Coronary Artery Disease
- DES
- DCB
- (no location specified)
Feb 20, 2023
Coronary Artery Disease Trial in Washington (PCI with SELUTION SLR DCB, PCI with FDA approved "-limus" DES)
Not yet recruiting
- Coronary Artery Disease
- PCI with SELUTION SLR DCB
- PCI with FDA approved "-limus" DES
-
Washington, District of ColumbiaMedStar Washington Hospital Center
Jul 7, 2023
Intracranial Atherosclerosis, Stroke Trial in Beijing (drug coated balloon, stent system)
Recruiting
- Intracranial Atherosclerosis
- Stroke
- drug coated balloon
- stent system
-
Beijing, ChinaBeijing Tiantan Hospital
Aug 17, 2022
Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)
Recruiting
- Acute Myeloid Leukemia, Adult
- cladribine + homoharringtonine + cytarabine
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023
Renal Transplantation Trial (TCD601, belatacept, ATG)
Not yet recruiting
- Renal Transplantation
- TCD601
- +5 more
- (no location specified)
Dec 20, 2022
Germline and Somatic Pathogenic Variants in de Novo Metastatic
Active, not recruiting
- Metastatic Breast Cancer
- NGS in blood and Formalin-Fixed Paraffin-Embedded (FFPE) tissue
-
Athens, GreeceEvangelia Moirogiorgou
Mar 7, 2023
De Novo Lipogenesis (DNL) Trial in Basel (Assessment of de novo lipogenesis non-invasively in exhaled breath)
Completed
- De Novo Lipogenesis (DNL)
- Assessment of de novo lipogenesis non-invasively in exhaled breath
-
Basel, SwitzerlandUniversity Children's Hospital Basel (UKBB)
Nov 3, 2022
Peripheral Artery Disease (PAD) Trial (Stent PULSAR® -18 T3,)
Not yet recruiting
- Peripheral Artery Disease (PAD)
- Stent PULSAR® -18 T3,
- (no location specified)
Dec 26, 2022
Coronary Heart Disease Trial in Beijing (drug-coated balloon)
Recruiting
- Coronary Heart Disease
- drug-coated balloon
-
Beijing, Beijing, ChinaBeijing Hospital
Sep 25, 2022
Coronary Artery Disease Trial in Ulsan (GENOSS® DCB, SeQuent® Please NEO)
Active, not recruiting
- Coronary Artery Disease
- GENOSS® DCB
- SeQuent® Please NEO
-
Ulsan, Korea, Republic ofUlsan University Hospital
Jan 29, 2023
Breast Tumors, Treatment, Metastatic Breast Cancer Trial (surgical treatment 1, surgical treatment 2, Systemic therapy)
Not yet recruiting
- Breast Neoplasms
- +3 more
- surgical treatment 1
- +2 more
- (no location specified)
Jul 17, 2022
De Novo Stenosis, Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Xi'an (Lepu Paclitaxel coated balloon,
Recruiting
- De Novo Stenosis
- +2 more
- Lepu Paclitaxel coated balloon
- +4 more
-
Xi'an, Shannxi, ChinaLing Tao
Jul 20, 2022
Renal Transplant Trial in Seoul (Rituximab, intravenous immune globulin)
Completed
- Renal Transplant
- Rituximab
- intravenous immune globulin
-
Seoul, Korea, Republic of
- +1 more
Oct 25, 2022
Adolescent Obesity Trial in New York (Fructose + Glucose Beverage)
Recruiting
- Adolescent Obesity
- Fructose + Glucose Beverage
-
New York, New YorkWeill Cornell Medicial College
Sep 16, 2022